IS2053B - Notkun kolsýruanhýdrasablokkara við meðferð á bjúgi í sjónudepli (macular edema) - Google Patents

Notkun kolsýruanhýdrasablokkara við meðferð á bjúgi í sjónudepli (macular edema)

Info

Publication number: IS2053B
Authority: IS; Iceland
Prior art keywords: carbonic anhydrase; blockers; treatment; macular edema; cai
Prior art date: 1996-02-26

Application number

IS4829A

Other languages

English (en)

Other versions

IS4829A (is

Inventor

Eric Sponsel William

Harris Alon

Original Assignee

Advanced Research And Technology Institute

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-26

Filing date

1998-08-20

Publication date

2005-10-14

1996-03-18 Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en

1998-08-20 Application filed by Advanced Research And Technology Institute filed Critical Advanced Research And Technology Institute

1998-08-20 Publication of IS4829A publication Critical patent/IS4829A/is

2005-10-14 Publication of IS2053B publication Critical patent/IS2053B/is

Links

206010025415 Macular oedema Diseases 0.000 title abstract 2
201000010230 macular retinal edema Diseases 0.000 title abstract 2
102000003846 Carbonic anhydrases Human genes 0.000 title 1
108090000209 Carbonic anhydrases Proteins 0.000 title 1
208000001344 Macular Edema Diseases 0.000 title 1
229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 2
239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 2
206010064930 age-related macular degeneration Diseases 0.000 abstract 1
208000002780 macular degeneration Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Eye Examination Apparatus (AREA)

IS4829A 1996-02-26 1998-08-20 Notkun kolsýruanhýdrasablokkara við meðferð á bjúgi í sjónudepli (macular edema) IS2053B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1225096P	1996-02-26	1996-02-26
GBGB9605642.9A GB9605642D0 (en)	1996-03-18	1996-03-18	Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en)	1996-02-26	1997-02-25	Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number	Publication Date
IS4829A IS4829A (is)	1998-08-20
IS2053B true IS2053B (is)	2005-10-14

Family

ID=26308946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4829A IS2053B (is)	1996-02-26	1998-08-20	Notkun kolsýruanhýdrasablokkara við meðferð á bjúgi í sjónudepli (macular edema)

Country Status (26)

Country	Link
EP (1)	EP0954305B9 (is)
JP (1)	JP4392481B2 (is)
KR (1)	KR100471586B1 (is)
CN (1)	CN1225582A (is)
AT (1)	ATE239468T1 (is)
AU (1)	AU727565B2 (is)
BG (1)	BG64525B1 (is)
BR (1)	BR9707674A (is)
CA (1)	CA2247063C (is)
CZ (1)	CZ299509B6 (is)
DE (1)	DE69721824T2 (is)
DK (1)	DK0954305T3 (is)
EA (1)	EA001681B1 (is)
EE (1)	EE03804B1 (is)
ES (1)	ES2199348T4 (is)
HU (1)	HU227161B1 (is)
IL (1)	IL125912A0 (is)
IS (1)	IS2053B (is)
MX (1)	MXPA98006961A (is)
NO (1)	NO320043B1 (is)
NZ (1)	NZ331843A (is)
PT (1)	PT954305E (is)
SK (1)	SK284371B6 (is)
TR (1)	TR199801665T2 (is)
WO (1)	WO1997030704A2 (is)
YU (1)	YU49422B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
EP1058546A4 (en) *	1998-03-06	2004-07-28	Univ Texas	COMPILATIONS AND METHODS FOR THE TREATMENT OF MACULA DISEASES
US5948801A (en) *	1998-03-09	1999-09-07	Alcon Laboratories, Inc.	Treatment of retinal edema with brinzolamide
CA2336703A1 (en) *	1998-07-10	2000-01-20	The University Of Sydney	Prophylactic treatments of neovascularisation in macular degeneration
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor
CA2671137A1 (en)	2006-12-15	2008-06-26	Nicox S.A.	Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) *	2010-12-09	2013-04-24	Fovea Pharmaceuticals	Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
JP2020504711A (ja)	2016-12-21	2020-02-13	バイオセリックス，インコーポレイテッド	タンパク質を標的とすることにおいて使用するための、チエノピロール誘導体、その組成物、方法、および使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4797413A (en) *	1986-05-14	1989-01-10	Merck & Co., Inc.	Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) *	1988-09-29	1992-03-18	American Cyanamid Co	Stable ophthalmic preparations containing methazolamide
US5153192A (en) *	1990-04-09	1992-10-06	Alcon Laboratories, Inc.	Thiophene sulfonamides useful as carbonic anhydrase inhibitors

1997
- 1997-02-25 TR TR1998/01665T patent/TR199801665T2/xx unknown
- 1997-02-25 EE EE9800263A patent/EE03804B1/xx not_active IP Right Cessation
- 1997-02-25 PT PT97907822T patent/PT954305E/pt unknown
- 1997-02-25 AT AT97907822T patent/ATE239468T1/de not_active IP Right Cessation
- 1997-02-25 AU AU19721/97A patent/AU727565B2/en not_active Ceased
- 1997-02-25 MX MXPA98006961A patent/MXPA98006961A/es active IP Right Grant
- 1997-02-25 CZ CZ0269998A patent/CZ299509B6/cs not_active IP Right Cessation
- 1997-02-25 ES ES97907822T patent/ES2199348T4/es not_active Expired - Lifetime
- 1997-02-25 NZ NZ331843A patent/NZ331843A/xx not_active IP Right Cessation
- 1997-02-25 IL IL12591297A patent/IL125912A0/xx not_active IP Right Cessation
- 1997-02-25 HU HU9902054A patent/HU227161B1/hu not_active IP Right Cessation
- 1997-02-25 WO PCT/US1997/002874 patent/WO1997030704A2/en not_active Ceased
- 1997-02-25 BR BR9707674-0A patent/BR9707674A/pt not_active Application Discontinuation
- 1997-02-25 EA EA199800764A patent/EA001681B1/ru not_active IP Right Cessation
- 1997-02-25 DK DK97907822T patent/DK0954305T3/da active
- 1997-02-25 SK SK1151-98A patent/SK284371B6/sk not_active IP Right Cessation
- 1997-02-25 DE DE69721824T patent/DE69721824T2/de not_active Expired - Lifetime
- 1997-02-25 KR KR10-1998-0706643A patent/KR100471586B1/ko not_active Expired - Fee Related
- 1997-02-25 CA CA002247063A patent/CA2247063C/en not_active Expired - Fee Related
- 1997-02-25 YU YU35398A patent/YU49422B/sh unknown
- 1997-02-25 CN CN97192579A patent/CN1225582A/zh active Pending
- 1997-02-25 EP EP97907822A patent/EP0954305B9/en not_active Expired - Lifetime
- 1997-02-25 JP JP53037997A patent/JP4392481B2/ja not_active Expired - Fee Related
1998
- 1998-08-20 IS IS4829A patent/IS2053B/is unknown
- 1998-08-25 NO NO19983906A patent/NO320043B1/no not_active IP Right Cessation
- 1998-09-25 BG BG102797A patent/BG64525B1/bg unknown

Also Published As

Publication number	Publication date
ES2199348T4 (es)	2010-10-19
AU727565B2 (en)	2000-12-14
BG64525B1 (bg)	2005-06-30
DE69721824D1 (de)	2003-06-12
NZ331843A (en)	2000-09-29
YU49422B (sh)	2006-01-16
YU35398A (sh)	2001-12-26
TR199801665T2 (xx)	1998-12-21
IS4829A (is)	1998-08-20
BR9707674A (pt)	2000-01-04
EE03804B1 (et)	2002-08-15
AU1972197A (en)	1997-09-10
DK0954305T3 (da)	2003-08-25
EA001681B1 (ru)	2001-06-25
CN1225582A (zh)	1999-08-11
HUP9902054A3 (en)	2001-07-30
CA2247063A1 (en)	1997-08-28
JP2000506833A (ja)	2000-06-06
SK284371B6 (sk)	2005-02-04
KR19990087242A (ko)	1999-12-15
HU227161B1 (en)	2010-09-28
NO983906L (no)	1998-10-19
SK115198A3 (en)	2000-01-18
EP0954305B9 (en)	2010-08-04
BG102797A (en)	1999-09-30
EE9800263A (et)	1999-08-16
MXPA98006961A (es)	2004-11-19
CA2247063C (en)	2004-01-06
PT954305E (pt)	2003-09-30
DE69721824T2 (de)	2004-03-11
EP0954305A2 (en)	1999-11-10
EA199800764A1 (ru)	1999-06-24
KR100471586B1 (ko)	2005-07-11
WO1997030704A2 (en)	1997-08-28
WO1997030704A3 (en)	1997-09-25
HUP9902054A1 (hu)	2000-03-28
CZ269998A3 (cs)	2000-01-12
ES2199348T3 (es)	2004-02-16
JP4392481B2 (ja)	2010-01-06
EP0954305B1 (en)	2003-05-07
NO320043B1 (no)	2005-10-17
IL125912A0 (en)	1999-04-11
NO983906D0 (no)	1998-08-25
ATE239468T1 (de)	2003-05-15
CZ299509B6 (cs)	2008-08-20

Publication	Publication Date	Title
IS4829A (is)	1998-08-20	Notkun kolsýruanhýdrasablokkara við meðferð á bjúgi í sjónudepli (macular edema)
NZ309523A (en)	1999-11-29	Peptidyl heterocycles useful in the treatment of thrombin related disorders
AU2306199A (en)	1999-07-05	Method and apparatus to medically treat soft tissue damage, lymphedema and edema
ES543862A0 (es)	1986-12-16	Procedimiento para apreciar variaciones en el tiempo de caracteristicas somaticas de personas sometidas a tratamiento deadelgazamiento, cicatrizacion y otros.
DE69311101D1 (de)	1997-07-03	Verfahren sowie anordnung zum herstellen von wundverbänden sowie mit diesem verfahren hergestellter wundverband
WO2000059487A3 (en)	2001-08-16	Flupirtine in the treatment of fibromyalgia and related conditions
UA32429C2 (uk)	2000-12-15	Засіб для лікування нетримання сечі
IS1930B (is)	2004-05-18	Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
DE69404547D1 (de)	1997-09-04	Gewebe-Gummi-Komplex, diesen verwendender Keilrippenriemen und Herstellungsverfahren eines Keilrippenriemes
DK91793A (da)	1995-01-31	Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf
DK0800481T3 (da)	1999-05-10	Fremgangsmåde og indretning til reduktion af nitratindholdet i vand
PL328833A1 (en)	1999-02-15	Application of carbonic anhydrase inhibitor in treating the macula oedema
YU42298A (sh)	1999-09-27	Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE69717846D1 (de)	2003-01-23	Behandlungsverfahren von laktamen
FI20010203A0 (fi)	2001-02-05	Menetelmä rainan vaihtamiseksi rullaimessa sekä menetelmässä käytettävä nauha
DE69818809D1 (de)	2003-11-13	Verfahren zur behandlung von narbengewebe
ES2058349T3 (es)	1994-11-01	Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.
WO1996036339A3 (en)	1997-02-13	Use of dihydrotestosterone compounds for treating male sexual dysfunction
NO984198L (no)	1998-11-02	FremgangsmÕte for behandling av aggresjon
SE9602145D0 (sv)	1996-05-31	New improved formulation for treatment of thromboembolism
FI972637A0 (fi)	1997-06-19	K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
UA23123A (uk)	1998-06-30	Спосіб хірургічhого лікуваhhя hавколососочкових виразок дваhадцятипалої кишки
RU99105312A (ru)	2001-01-10	Способ лечения гастродуоденальных язв
UA25549A (uk)	1998-12-25	Спосіб профілактики і лікуваhhя гhійhо-резорбтивhих ускладhеhь після пологів
UA31588A (uk)	2000-12-15	Спосіб лікування виразки дванадцятипалої кишки, ускладненої кровотечею